Oncology Institute Shares Rise After Higher 1Q Revenue

Dow Jones

May 15, 2025

By Chris Wack

Oncology Institute shares were 22% higher, at $2.89, after the company reported first-quarter revenue that was 10% higher than last year, and a narrower loss.

The medical services company said it had quarterly revenue of $104.4 million, compared with $94.7 million in the same quarter last year.

The company said it had a loss of $19.6 million, or 21 cents a share, compared with last year's loss of $19.9 million, or 22 cents a share.

Oncology Institute said the positive change in loss from operations from last year was offset primarily by non-cash charges related to interest expense and the fair value of derivative liabilities. It said it expects to see full-year profitability in 2026.

For fiscal 2025, the company is expecting revenue of $460 million to $480 million.

The company has cash and cash equivalents of $39.7 million as of March 31.

Write to Chris Wack at chris.wack@wsj.com

(END) Dow Jones Newswires

May 15, 2025 10:50 ET (14:50 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2535822409"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2535822409\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2535822409?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-15 22:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2535822409","market":"hk","top_or_hot":-1,"title":"Oncology Institute Shares Rise After Higher 1Q Revenue","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Chris Wack \n</p>\n<pre>\n \n</pre>\n<p>\n  Oncology Institute shares were 22% higher, at $2.89, after the company reported first-quarter revenue that was 10% higher than last year, and a narrower loss. \n</p>\n<p>\n  The medical services company said it had quarterly revenue of $104.4 million, compared with $94.7 million in the same quarter last year. \n</p>\n<p>\n  The company said it had a loss of $19.6 million, or 21 cents a share, compared with last year's loss of $19.9 million, or 22 cents a share. \n</p>\n<p>\n  Oncology Institute said the positive change in loss from operations from last year was offset primarily by non-cash charges related to interest expense and the fair value of derivative liabilities. It said it expects to see full-year profitability in 2026. \n</p>\n<p>\n  For fiscal 2025, the company is expecting revenue of $460 million to $480 million. \n</p>\n<p>\n  The company has cash and cash equivalents of $39.7 million as of March 31. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Chris Wack at chris.wack@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 15, 2025 10:50 ET (14:50 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Oncology Institute Shares Rise After Higher 1Q Revenue</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOncology Institute Shares Rise After Higher 1Q Revenue\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-05-15 22:50</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Chris Wack \n</p>\n<pre>\n \n</pre>\n<p>\n  Oncology Institute shares were 22% higher, at $2.89, after the company reported first-quarter revenue that was 10% higher than last year, and a narrower loss. \n</p>\n<p>\n  The medical services company said it had quarterly revenue of $104.4 million, compared with $94.7 million in the same quarter last year. \n</p>\n<p>\n  The company said it had a loss of $19.6 million, or 21 cents a share, compared with last year's loss of $19.9 million, or 22 cents a share. \n</p>\n<p>\n  Oncology Institute said the positive change in loss from operations from last year was offset primarily by non-cash charges related to interest expense and the fair value of derivative liabilities. It said it expects to see full-year profitability in 2026. \n</p>\n<p>\n  For fiscal 2025, the company is expecting revenue of $460 million to $480 million. \n</p>\n<p>\n  The company has cash and cash equivalents of $39.7 million as of March 31. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Chris Wack at chris.wack@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 15, 2025 10:50 ET (14:50 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TOI","symbol_name":"The Oncology Institute","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2535822409","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2535822409","pubTimestamp":1747320600,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Oncology Institute shares were 22% higher, at $2.89, after the company reported first-quarter revenue that was 10% higher than last year, and a narrower loss.The medical services company said it had quarterly revenue of $104.4 million, compared with $94.7 million in the same quarter last year.The company said it had a loss of $19.6 million, or 21 cents a share, compared with last year's loss of $19.9 million, or 22 cents a share.Oncology Institute said the positive change in loss from operations from last year was offset primarily by non-cash charges related to interest expense and the fair value of derivative liabilities. It said it expects to see full-year profitability in 2026.For fiscal 2025, the company is expecting revenue of $460 million to $480 million.The company has cash and cash equivalents of $39.7 million as of March 31.","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"TOI":"The Oncology Institute"},"translate_title":"第一季度收入增加后肿瘤研究所股价上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TOI":0.9},"content_text":"By Chris Wack \n\n\n \n\n\n  Oncology Institute shares were 22% higher, at $2.89, after the company reported first-quarter revenue that was 10% higher than last year, and a narrower loss. \n\n\n  The medical services company said it had quarterly revenue of $104.4 million, compared with $94.7 million in the same quarter last year. \n\n\n  The company said it had a loss of $19.6 million, or 21 cents a share, compared with last year's loss of $19.9 million, or 22 cents a share. \n\n\n  Oncology Institute said the positive change in loss from operations from last year was offset primarily by non-cash charges related to interest expense and the fair value of derivative liabilities. It said it expects to see full-year profitability in 2026. \n\n\n  For fiscal 2025, the company is expecting revenue of $460 million to $480 million. \n\n\n  The company has cash and cash equivalents of $39.7 million as of March 31. \n\n\n \n\n\n  Write to Chris Wack at chris.wack@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 15, 2025 10:50 ET (14:50 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}